Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Accelrys Announces Software Licensing Agreement with Gulf Coast Consortia

Published: Saturday, June 02, 2012
Last Updated: Saturday, June 02, 2012
Bookmark and Share
Tailored academic license defines new informatics standard for multi-center collaborative research and Cloud-based data sharing

Accelrys, Inc. (NASDAQ: ACCL), a leading enterprise R&D software and services company, today announced that the Gulf Coast Consortia (GCC) for Quantitative Biomedical Sciences has signed a five-year licensing agreement with Accelrys to provide investigators in the GCC Chemical Genomics (GCC-CG) program with access to scientific software, services and training. The Accelrys software will be used to support multi-disciplinary collaborative research and training programs for the treatment and prevention of diseases, including rare and undertreated cancers.

To view the multimedia assets associated with this release, please click here 

Offered through the Accelrys Academic Program, the licensed software includes the scientifically enabled, enterprise-scalable Accelrys Enterprise Platform supporting multi-center, collaborative information sharing and scientific innovation across partnering research organizations. The system also includes Accelrys Pipeline Pilot™ (the platform's scientific authoring solution), the Cloud-based Accelrys HEOS®  drug discovery information management workspace, the Accelrys Discovery Studio® modeling and simulation application and Accelrys Biological Registration software.

"Plug-and-play deployment and ease of use in a seamless integrated network requiring minimal support by internal resources were the driving factors that led our group to adopt Accelrys technology," said GCC-CG director and co-founder Dr. Peter Davies, professor and director of the Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M Health Center. "With upwards of thirty projects a year, we need to work together efficiently and generate results quickly with minimal time and resources spent on internal software development. The ability to create Pipeline Pilot Web applications that can be freely shared with other academic researchers inside or outside the Consortia provides a significant collaboration and innovation benefit."

Dr. Michael Mancini, associate professor in the department of Molecular and Cellular Biology at Baylor College of Medicine, and co-founder/co-director of the GCC-CG added "For several years, our assay development efforts and screening program have always had a sizable high throughput microscopy-based emphasis using Pipeline Pilot-based imaging tools. We are extremely pleased to now be able to integrate high content analysis/screening data and reporting across the entire program using HEOS."

The mission of the GCC is to build and support interdisciplinary collaborative research teams and training programs in the biological sciences and apply the resulting expertise and knowledge to the treatment and prevention of diseases. The GCC brings together preeminent principal investigators from several world-renowned research institutions including the founding members:

  • Baylor College of Medicine
  • Rice University
  • University of Houston
  • University of Texas Health Science Center at Houston (UTHealth)
  • University of Texas MD Anderson Cancer Center
  • University of Texas Medical Branch at Galveston

In addition to the GCC founding institutions, the GCC-CG includes The Methodist Hospital Research Institute, The University of Texas at Austin - Texas Institute for Drug and Diagnostic Development, Texas A&M Health Science Center — Institute for Biosciences and Technology, Texas Southern University and The University of Texas-El Paso.

"Large inter-institutional cooperatives focused on collaborative research and interdisciplinary training represent a new operating paradigm in academia today," said Accelrys Senior Vice President and Chief Technology Officer, Dr. Matt Hahn. "Accelrys' unifying Enterprise Platform defines a new standard in integrated research informatics for multi-center collaborations. The software package tailored for GCC and delivered through Accelrys' Academic Program provides immediate access to shared state-of-the-art solutions, enabling university partners to hit the ground running with project delivery."

Accelrys, Inc. (NASDAQ: ACCL), a leading enterprise R&D software and services company, today announced that the Gulf Coast Consortia (GCC) for Quantitative Biomedical Sciences has signed a five-year licensing agreement with Accelrys to provide investigators in the GCC Chemical Genomics (GCC-CG) program with access to scientific software, services and training. The Accelrys software will be used to support multi-disciplinary collaborative research and training programs for the treatment and prevention of diseases, including rare and undertreated cancers.

Offered through the Accelrys Academic Program, the licensed software includes the scientifically enabled, enterprise-scalable Accelrys Enterprise Platform supporting multi-center, collaborative information sharing and scientific innovation across partnering research organizations. The system also includes Accelrys Pipeline Pilot™ (the platform's scientific authoring solution), the Cloud-based Accelrys HEOS®  drug discovery information management workspace, the Accelrys Discovery Studio® modeling and simulation application and Accelrys Biological Registration software.

"Plug-and-play deployment and ease of use in a seamless integrated network requiring minimal support by internal resources were the driving factors that led our group to adopt Accelrys technology," said GCC-CG director and co-founder Dr. Peter Davies, professor and director of the Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M Health Center. "With upwards of thirty projects a year, we need to work together efficiently and generate results quickly with minimal time and resources spent on internal software development. The ability to create Pipeline Pilot Web applications that can be freely shared with other academic researchers inside or outside the Consortia provides a significant collaboration and innovation benefit."

Dr. Michael Mancini, associate professor in the department of Molecular and Cellular Biology at Baylor College of Medicine, and co-founder/co-director of the GCC-CG added "For several years, our assay development efforts and screening program have always had a sizable high throughput microscopy-based emphasis using Pipeline Pilot-based imaging tools. We are extremely pleased to now be able to integrate high content analysis/screening data and reporting across the entire program using HEOS."

The mission of the GCC is to build and support interdisciplinary collaborative research teams and training programs in the biological sciences and apply the resulting expertise and knowledge to the treatment and prevention of diseases. The GCC brings together preeminent principal investigators from several world-renowned research institutions including the founding members:

Source: PR Newswire (http://s.tt/1cZBK)<div class="rpuEmbedCode">
  <!--rpuEmbedStart-->
  <script src="http://1.rp-api.com/rjs/repost-article.js?3" type="text/javascript" data-cfasync="false"></script>
  <div class="rpuArticle rpuRepost-c795416c5b9a2e7ae6f9f0f775ed8771-top" style="margin:0;padding:0;">
    <a href="./redirect.aspx?cid=139985&uid=000000&link=http://s.tt/1cZBK" class="rpuThumb" rel="norewrite"><img src="http://img.1.rp-api.com/thumb/2067097" style="float:left;margin-right:10px;" /></a>
    <a href="./redirect.aspx?cid=139985&uid=000000&link=http://s.tt/1cZBK" class="rpuTitle" rel="norewrite"><strong>Accelrys Announces Software Licensing Agreement with Gulf Coast Consortia</strong></a> (via <a href="./redirect.aspx?cid=139985&uid=000000&link=http://s.tt/1cZBK" class="rpuHost" rel="norewrite">PR Newswire</a>)
    <p class="rpuSnip">
       SAN DIEGO, May 30, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading enterprise R&D software and services company, today announced that the Gulf Coast Consortia (GCC) for Quantitative Biomedical Sciences has signed a five-year licensing agreement with Accelrys to provide investigators&hellip;
    </p>
  </div>
  <!-- put the "tease", "jump" or "more" break here --><!--more--><!--break--><div style="display: none;"><hr class="at-page-break" /></div>
  <div class="rpuArticle rpuRepostMain rpuRepost-c795416c5b9a2e7ae6f9f0f775ed8771-bottom" style="display:none;">&nbsp;</div>
  <!-- How to customize this embed: http://www.repost.us/article-preview/#!shash=c795416c5b9a2e7ae6f9f0f775ed8771 -->
</div><div class="rpuEmbedCode">
  <!--rpuEmbedStart-->
  <script src="http://1.rp-api.com/rjs/repost-article.js?3" type="text/javascript" data-cfasync="false"></script>
  <div class="rpuArticle rpuRepost-c795416c5b9a2e7ae6f9f0f775ed8771-top" style="margin:0;padding:0;">
    <a href="./redirect.aspx?cid=139985&uid=000000&link=http://s.tt/1cZBK" class="rpuThumb" rel="norewrite"><img src="http://img.1.rp-api.com/thumb/2067097" style="float:left;margin-right:10px;" /></a>
    <a href="./redirect.aspx?cid=139985&uid=000000&link=http://s.tt/1cZBK" class="rpuTitle" rel="norewrite"><strong>Accelrys Announces Software Licensing Agreement with Gulf Coast Consortia</strong></a> (via <a href="./redirect.aspx?cid=139985&uid=000000&link=http://s.tt/1cZBK" class="rpuHost" rel="norewrite">PR Newswire</a>)
    <p class="rpuSnip">
       SAN DIEGO, May 30, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading enterprise R&D software and services company, today announced that the Gulf Coast Consortia (GCC) for Quantitative Biomedical Sciences has signed a five-year licensing agreement with Accelrys to provide investigators&hellip;
    </p>
  </div>
  <!-- put the "tease", "jump" or "more" break here --><!--more--><!--break--><div style="display: none;"><hr class="at-page-break" /></div>
  <div class="rpuArticle rpuRepostMain rpuRepost-c795416c5b9a2e7ae6f9f0f775ed8771-bottom" style="display:none;">&nbsp;</div>
  <!-- How to customize this embed: http://www.repost.us/article-preview/#!shash=c795416c5b9a2e7ae6f9f0f775ed8771 -->
</div>


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,400+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Accelrys Announces 2012 US Tech Summit for IT Professionals
Fourth US Tech Summit for Accelrys customers will take place October 16-17 in New Jersey.
Sunday, October 21, 2012
Aquavit Pharmaceuticals Forms Alliance Partnership with Accelrys
Aquavit to utilize the Accelrys Enterprise Platform to develop advanced medical software for cutting-edge personalized medicine.
Sunday, October 14, 2012
Accelrys Acquires VelQuest Corporation for $35 Million in Cash
Extends reach downstream in the lab-to-market value chain with addition of industry-leading lab execution and data capture software
Monday, March 19, 2012
Accelrys Acquires VelQuest
Accelrys adds paperless lab execution systems to portfolio with acquisition of VelQuest Corporation.
Friday, January 06, 2012
Scientific News
Peptide Mutants Help Identify Vulnerability in Tumor Cells
Researchers can detect mutant proteins based on MS data and the results of exome sequencing.
An Emerging Model of Cancer
Cancer acts cooperatively, making individual decisions but acting in unison; this insight is being used to create a computer model of cancer.
Personalised Medicine: Dose by Design
Personalised medicine holds the promise of a new approach to healthcare, tailored exactly to our individual needs, as Congenica's Nick Lench discussed on a recent BBC Radio 4 programme.
Expanding Knowledge of Viral Diversity
Environmental datasets help researchers double the number of microbial phyla known to be infected by viruses.
Computers Better Predict Lung Cancer Type, Severity
Study shows automating the analysis of cancer tissue samples increases the accuracy of tumor classification and patient prognoses.
Using Big Data to Discover Potential Cancer Biomarkers
University of Hawai'i Cancer Center researchers used "Big Data" to discover potential cancer biomarkers, a panel of six long intergenic non-coding RNAs (lincRNAs), for the diagnosis of all types of cancers including lung, breast, prostate, liver and ovarian cancers.
Protecting Privacy in Genomic Databases
System helps ensure databases used in medical research will not leak patients’ personal information.
Algorithm To Find Precise Cancer Treatments For Patients Developed
The JAMMIT algorithm could help predict which patients will benefit most from chemotherapy.
Depression Genetics Insight from Crowd-Sourced Data
Genome sites liked to depression have been discovered from data shared by people who had purchased their genetic profiles online.
Detecting Hazardous Chemicals in Complex Mixtures
Researchers are pioneering a new chemical substance analyis software technique that could increase illicit substance detection.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!